Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)

This document (A59832) is a response-to-comments summary and does not contain standalone coverage criteria for implantable continuous glucose monitors. Review the final Local Coverage Determination DL38617 for specific indications, exclusions, documentation requirements, and frequency limits; manual review of DL38617 is required to extract actionable billing and coverage criteria.

"This document is a response-to-comments summary and contractor responses; it does not itself specify coverage criteria—refer to final Local Coverage Determination DL38617 (Implantable Continuous Gl..."

Sign up to see full coverage criteria, indications, and limitations.